Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.

This bill (S 1215) allows patients in New Jersey to formally indicate in the state's prescription monitoring program that they do not wish to receive prescriptions for opiates or certain other controlled substances. It directly affects patients who want to limit their access to these medications and healthcare providers who access the monitoring system when prescribing. The key mechanism requires the state division to maintain a record of these patient preferences within the prescription monitoring database, which would be visible to authorized prescribers and pharmacists. This change ensures patient preferences regarding controlled substances are documented and considered during prescription decisions, without altering the program's existing confidentiality rules or access protocols.